Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
publishDate:"[2000 TO 2099]"
publishDate:"[2010 TO 2019]"
topic_facet:"Study Type: Interventional"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2000+TO+2099%5D%22&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&lookfor=%22Young+Adult%22&type=Subject
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2000+TO+2099%5D%22&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&lookfor=%22Young+Adult%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2000+TO+2099%5D%22&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&lookfor=%22Young+Adult%22&type=Subject
PubPharm (113)
1
Two parts study, the first part is to determine the dose of azacitidine and the second part is to evaluate the effect of azacitidine compared to no treatment, in children and young adults following a molecular relapse of acute myeloid leukemia after the first complete remission. : A randomized, multicenter, open-label, Phase 2 study with a safety run-in part to evaluate safety,pharmacodynamics and efficacy of azacitidine compared to no anticancer treatment in childrenand young adults with acute myeloid leukemia in molecular relapse after first complete remission.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
2
Two parts study, the first part is to determine the dose of azacitidine and the second part is to evaluate the effect of azacitidine compared to no treatment, in children and young adults following a molecular relapse of acute myeloid leukemia after the first complete remission. : A randomized, multicenter, open-label, Phase 2 study with a safety run-in part to evaluate safety,pharmacodynamics and efficacy of azacitidine compared to no anticancer treatment in childrenand young adults with acute myeloid leukemia in molecular relapse after first complete remission.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
3
A clinical study to determine the efficacy and safety of tisagenlecleucel, an investigational therapy, in first-line high-risk children and adolescent patients with B-cell acute lymphoblastic leukemia who are minimal residual disease positive at the end of consolidation therapy : A phase II trial of tisagenlecleucel in first-line high-risk (HR) pediatric and young adult patients with B-cell acute lymphoblastic leukemia (B-ALL) who are minimal residual disease (MRD) positive at the end of consolidation (EOC) therapy - Study of efficacy and safety of tisagenlecleucel in HR B-ALL EOC MRD positive patients.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
4
A study to evaluate a risk-adapted treatment of extra cranial malignant germ cell in children, adolescent and young adult : A multicenter study to evaluate a risk-adapted strategy for treatment of extra cranial non seminomateous malignant germ cell tumour in children, adolescent and young adult - TGM 2013 - NS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
5
A trial for children and teenagers with Cyclin-dependent Kinase-like 5 (CDKL5) Deficiency Disorder (CDD) to determine how effective Ganaxolone treatment is. : A Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone Treatment in Children and Young Adults with Cyclin-dependent Kinase-like 5 (CDKL5) Deficiency Disorder (CDD) Followed by Long-term Open-label Treatment
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
6
A clinical study to provide the opportunity to be treated with CTL019, an investigational gene therapy, for children and adolescent patients with a recurrent form of B-cell acute lymphoblastic leukaemia after the closure of the Novartis single-arm phase II pivotal registration trial (Study CCTL019B2202) and to collect additional safety information. : Phase IIIb study for relapsed/refractory pediatric/young adult acute lymphoblastic leukemia patients to be treated with CTL019. - Phase IIIb study for CTL019.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
7
A clinical study to determine the efficacy and safety of tisagenlecleucel, an investigational therapy, in first-line high-risk children and adolescent patients with B-cell acute lymphoblastic leukemia who are minimal residual disease positive at the end of consolidation therapy : A phase II trial of tisagenlecleucel in first-line high-risk (HR) pediatric and young adult patients with B-cell acute lymphoblastic leukemia (B-ALL) who are minimal residual disease (MRD) positive at the end of consolidation (EOC) therapy - Study of efficacy and safety of tisagenlecleucel in HR B-ALL EOC MRD positive patients.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
8
A study to evaluate a risk-adapted treatment of extra cranial malignant germ cell in children, adolescent and young adult : A multicenter study to evaluate a risk-adapted strategy for treatment of extra cranial non seminomateous malignant germ cell tumour in children, adolescent and young adult - TGM 2013 - NS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
9
A trial for children and teenagers with Cyclin-dependent Kinase-like 5 (CDKL5) Deficiency Disorder (CDD) to determine how effective Ganaxolone treatment is. : A Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone Treatment in Children and Young Adults with Cyclin-dependent Kinase-like 5 (CDKL5) Deficiency Disorder (CDD) Followed by Long-term Open-label Treatment
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
10
A clinical study to provide the opportunity to be treated with CTL019, an investigational gene therapy, for children and adolescent patients with a recurrent form of B-cell acute lymphoblastic leukaemia after the closure of the Novartis single-arm phase II pivotal registration trial (Study CCTL019B2202) and to collect additional safety information. : Phase IIIb study for relapsed/refractory pediatric/young adult acute lymphoblastic leukemia patients to be treated with CTL019. - Phase IIIb study for CTL019.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2000-2099
Filter aufheben
Erscheinungsjahr: 2010-2019
Filter aufheben
Thema: Study Type: Interventional
Medienart
113
Aufsätze
113
E-Artikel
113
E-Ressourcen
Zeitschriftentitel
96
WHO International Clinical Trials Registry Plat...
17
ClinicalTrials.gov
Thema
113
610
Study Type: Interventional
38
Recruitment Status: Authorised-recruitment may ...
34
Recruitment Status: Not yet recruiting
19
Recruitment Status: Completed
16
Phase: Phase 2
14
Phase: Phase 3
13
Phase: Phase 4
6
Medical Condition: MS is a chronic disease of t...
6
Medical Condition: Pediatric and young adult pa...
5
Medical Condition: Healthy Young Adults
5
Phase: Phase 1
4
Medical Condition: Active (prophylactic) immuni...
4
Medical Condition: Diabetic Retinopathy and dia...
4
Medical Condition: Prevention of invasive menin...
4
Medical Condition: Treatment of seizures in chi...
4
Recruitment Status: Recruiting
2
Medical Condition: Booster vaccination with a p...
2
Medical Condition: Children and young adults up...
2
Medical Condition: Children and young adults wi...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2010-2019
29
2019
14
2018
18
2017
10
2016
14
2015
4
2014
6
2013
18
2012
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
111
Englisch
2
Unbestimmt
Haven't found what you're looking for?
Wird geladen...